# Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients

> **NCT00953108** · PHASE3 · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 60 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** quetiapine
- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT00953108
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953108, "Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00953108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*